Loading market data...
Latest Top News
Jagsonpal Pharma Board Clears Rs 400 Million Buyback
Jagsonpal Pharmaceuticals Ltd has approved a share buyback worth Rs 400 million, setting the buyback price at Rs 250 per equity share. The move is aimed at enhancing shareholder value, optimizing capital allocation, and reinforcing investor confidence in the company’s long-term growth strategy.
Stay Ahead – Explore Now! RBI Sets Underwriting Commitment for New Government Bond Auction






